IMPACT BIOMEDICAL INC.
For the period ended Dec 31, 2025. Filed Mar 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 11, 2026
IBO$4.33+5.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| Common Stock · Preferred Stock · Additional Paid-in · Accumulated · Total Impact · Non- controlling Interest in | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Deficit · Equity · Subsidiary · Total | ||||||||||
| Balance, December 31, 2023 | 10,000,000 | $10,000 | 60,496,041 | $60,000 | $38,113,000 | $(12,961,000) | $25,222,000 | 3,040,000 | $28,262,000 | |
| - | ||||||||||
| Issuance of common stock, net of expenses | 1,500,000 | 1,000 | - | - | 3,725,000 | - | 3,726,000 | - | 3,726,000 | |
| Stock based payments | - | - | - | - | 19,000 | - | 19,000 | - | 19,000 | |
| Fractional shares as a result of reverse stock split | 3,955 | - | - | - | - | - | - | - | - | |
| Net loss | - | - | - | - | - | (24,708,000) | (24,708,000) | (62,000) | (24,770,000) | |
| Balance, December 31, 2024 | 11,503,955 | $11,000 | 60,496,041 | $60,000 | $41,857,000 | $(37,669,000) | $4,259,000 | $2,978,000 | $7,237,000 | |
| Balance, December 31, 2024 | 11,503,955 | $11,000 | 60,496,041 | $60,000 | $41,857,000 | $(37,669,000) | $4,259,000 | $2,978,000 | $7,237,000 | |
| Conversion of note payable, related party to equity | 31,939,778 | 33,000 | - | - | 19,132,000 | - | 19,165,000 | - | 19,165,000 | |
| Conversion of preferred shares into common shares | 60,496,041 | 60,000 | (60,496,041) | (60,000) | - | - | - | - | - | |
| Acquisition of DSS PureAir assets | 545,024 | 1,000 | - | - | 819,000 | - | 820,000 | 820,000 | ||
| Stock based compensation | - | - | - | - | 13,000 | - | 13,000 | - | 13,000 | |
| Stock based payments for professional services rendered | 136,433 | - | - | - | 190,000 | - | 190,000 | - | 190,000 | |
| Net loss | - | - | - | - | - | (11,838,000) | (11,838,000) | (32,000) | (11,870,000) | |
| Balance, December 31, 2025 | 104,621,231 | $105,000 | - | $ | - | $62,011,000 | $(49,507,000) | $12,609,000 | $2,946,000 | $15,555,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.